Prostatic specific antigen abnormal and Injection site swelling

Summary:

Injection site swelling is reported only by a few people with Prostatic specific antigen abnormal.

The study analyzes which people have Injection site swelling with Prostatic specific antigen abnormal. It is created by eHealthMe based on 5 people who have Injection site swelling and Prostatic specific antigen abnormal from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 19, 2023

5 people who have Prostatic Specific Antigen Abnormal and Injection Site Swelling are studied.

What is Prostatic specific antigen abnormal?

Prostatic specific antigen abnormal is found to be associated with 285 drugs and 127 conditions by eHealthMe.

What is Injection site swelling?

Injection site swelling is found to be associated with 1,778 drugs and 1,058 conditions by eHealthMe.

Number of Injection site swelling in Prostatic specific antigen abnormal reports submitted per year:

Would you have Injection site swelling when you have Prostatic specific antigen abnormal?

Gender of people who have Prostatic Specific Antigen Abnormal and experienced Injection Site Swelling *:

female: 75 %
male: 25 %

Age of people who have Prostatic Specific Antigen Abnormal and experienced Injection Site Swelling *:

Common co-existing conditions for these people *:

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 20.00%
Pain: 1 person, 20.00%
Neuropathy Peripheral (surface nerve damage): 1 person, 20.00%
Hypersensitivity: 1 person, 20.00%
High Blood Pressure: 1 person, 20.00%
High Blood Cholesterol: 1 person, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 20.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Injection Site Pruritus (severe itching at injection site): 3 people, 60.00%
Injection Site Pain: 3 people, 60.00%
Injection Site Erythema (redness at injection site): 3 people, 60.00%
Nerve Compression: 1 person, 20.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 1 person, 20.00%
Injection Site Reaction: 1 person, 20.00%
High Blood Pressure: 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site swelling?

Check whether Injection site swelling is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Prostatic specific antigen abnormal (765 reports)
Injection site swelling (58,863 reports)

COVID vaccines that are related to Injection site swelling:

Common drugs associated with Injection site swelling:

All the drugs that are associated with Injection site swelling:

Injection site swelling (1,778 drugs)

Common conditions associated with Injection site swelling:

Rheumatoid arthritis: 16,901 reports
Psoriasis: 5,693 reports
Multiple sclerosis: 2,403 reports
Crohn's disease: 2,386 reports

All the conditions that are associated with Injection site swelling:

Injection site swelling (1,058 conditions)

How the study uses the data?

The study is based on Injection site swelling and Prostatic specific antigen abnormal, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.